Evidence map›Paper›PMID 38936909›Full record

ArticleIn vivo (Athens, Greece)

Fe

Stamatiki Grammatikaki, Vanessa-Meletia Bala, Hector Katifelis, Dimitra Ioanna Lampropoulou, Iuliia Mukha, Nadiia Vityuk, Nefeli Lagopati, Vassilios Kouloulias, Gerasimos Aravantinos, Maria Gazouli

Abstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stamatiki Grammatikaki *Laboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Vanessa-Meletia Bala *Hygeia Hospital, Marousi, Greece.
Hector KatifelisLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Dimitra Ioanna LampropoulouECONCARE, Athens, Greece.
Iuliia MukhaChuiko Institute of Surface Chemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
Nadiia VityukChuiko Institute of Surface Chemistry, National Academy of Sciences of Ukraine, Kyiv, Ukraine.
Nefeli LagopatiLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Vassilios KoulouliasRadiation Oncology Unit, 2nd Department of Radiology, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Gerasimos AravantinosEuroclinic, Athens, Greece.
Maria GazouliLaboratory of Biology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; mgazouli@med.uoa.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimHyperthermia represents an adjuvant local anticancer strategy which relies on the increase of temperature beyond the physiological level. In this study, we investigated the anticancer potential of Fe MATERIALS AND

methodsThe human breast cancer cell line SK-BR-1 was incubated with either Fe

resultsAt each concentration tested, Fe

conclusionBoth Fe

Indexed as

Breast NeoplasmsCell Cycle ProteinsCell ProliferationDNA Topoisomerases, Type IIHyperthermia, InducedKi-67 AntigenMicrotubule-Associated ProteinsPoly-ADP-Ribose Binding ProteinsBiomarkers, TumorCell Line, TumorFemaleGene Expression Regulation, NeoplasticHEK293 CellsHumansBiomarkers, TumorCell Cycle ProteinsDNA Topoisomerases, Type IIKi-67 AntigenMicrotubule-Associated ProteinsPoly-ADP-Ribose Binding ProteinsTOP2A protein, humanTPX2 protein, humanhyperthermiaKi-67MagnetiteSK-BR-3TOP2ATPX2

Identifiers

PMID38936909
PMCPMC11215606

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.